Weekly Research Updates & Guidance

Please check this page regularly for guidance and research updates.

Last updated: 5/13/26

NIH General Announcements and Notices of Special Interest

Notice of NIAID Participation in RFA-HL-26-017, Catalyze:

Product Definition for Small Molecules, Biologics and Combination Products-Target Identification and Validation, and Preliminary Product/Lead Series Identification (R61/R33)

Notice of NIAID Participation in RFAHL-26-018, Catalyze:

Product Definition Small Molecules, Biologics and Combination Products-, and Preliminary Product/Lead Series Identification and Combination Product Prototype(R33 – Clinical Trial Not Allowed)

Notice of Change: Expiration of RFA-DK-26-309

– Single Source Renewal for the Liver Cirrhosis Network: Scientific and Data Coordination Center (U24 Clinical Trial Optional)

Notice of Change: Expiration of RFA-DK-26-308

Limited Competition Renewal for the Continuation of the Liver Cirrhosis Network: Clinical Research Center (U01 Clinical Trial Required.

Update to Standard Language for Developer Terms of Access in the Terms and Conditions of Award

(NOT-OD-26-078)

National Institutes of Health

This Notice updates previous Developer Terms of Access (NOT-OD-25-021) so that the terms apply to NIH Controlled-Access Data Repositories whose controlled studies may or may not be subject to the NIH GDS Policy. The Notice addresses:

Expectations for Developer Use Statement and Overview of NIH Developer Data Access Committee
Public Posting of Approved Developer Use
Non-Identification
Certificate of Confidentiality
Non-Transferability
Data Security Training
Data Security and Unauthorized Data Release
Terms of Access Violation
Developer Use Reporting
Non-Endorsement, Indemnification
Lower Tier Agreements
Termination and Data Destruction

Update - NIH Implementation of Uniform Administrative Requirements for Federal Financial Assistance

(NOT-OD-26-072)

National Institutes of Health

This Notice updates NIH’s implementation of the Uniform Administrative Requirements, Cost Principles, and Audit Requirements. Updates made in the 2024 revisions of 2 CFR 200 are now included in the FY26 Grants Policy Statement (GPS) issued March 25, 2026. Under the Consolidated Appropriations Act for FY2026, provisions regarding indirect costs in 45 CFR 75 still apply to NIH awards. Due to this, the flexibilities outlined in Notice NOT-OD-25-059 are rescinded. This includes:

2 CFR 200.1 – Modified Total Direct Cost Definition - Calculating Indirect Costs
2 CFR 200.414(f) - De Minimis Indirect Rate

Announcement of Upcoming System Enforcement of Common Forms and End of NIH’s Leniency Period

(NOT-OD-26-079)

National Institutes of Health

Agency for Healthcare Research and Quality
Centers for Disease Control and Prevention
Department of Veterans Affairs

This Notice is a reminder the research community that the leniency period for Common Forms for Biographical Sketch and Current and Pending (Other) Support ends on May 7, 2026 which is the final AIDS standard receipt date for Cycle 1. System warnings will continue through the leniency period.

Regarding zero effort on Current and Pending (Other) Support, SciENcv and eRA started allowing zero person months for Proposals/Active Projects and In-Kind Contributions on the Current and Pending (Other) Support Form as of April 22,2026.

Also as of April 22,2026, SciENcv added the Research Security Training (RST) Certification back onto the Common Forms.

NSF – National Science Foundation General Announcements

Department of Defense (DOD)

Fiscal Year 2026 (FY26) program announcements for Department of War (DOW) programs managed by the Congressionally Directed Medical Research Programs (CDMRP).

Cost caps for all FY26 CDMRP funding opportunities are total costs (direct plus indirect costs).

FY26 program announcements released:

The Lupus Research Program (LRP) released program announcements for the following funding opportunities:

Idea Award
Impact Award
Transformative Vision Development Award
Transformative Vision Award

To view the LRP funding opportunity announcements and submit a pre-application, visit https://ebrap.org/eBRAP/public/ProgramFY.htm?programFYId=719112

The Multiple Sclerosis Research Program (MSRP) released program announcements for the following funding opportunities:

Clinical Trial Award
Early Investigator Research Award
Exploration - Hypothesis Research Award
Investigator - Initiated Research Award

To view the MSRP funding opportunity announcements and submit a pre-application, visit https://ebrap.org/eBRAP/public/ProgramFY.htm?programFYId=713102

The Tuberous Sclerosis Complex Research Program (TSCRP) released program announcements for the following funding opportunities:

Clinical Translational Research Award
Exploration-Hypothesis Research Award
Idea Development Award

To view the TSCRP funding opportunity announcements and submit a pre-application, visit https://ebrap.org/eBRAP/public/ProgramFY.htm?programFYId=713103

Fiscal Year 2026 (FY26) program announcements for Department of War (DOW) programs managed by the Congressionally Directed Medical Research Programs (CDMRP).

Cost caps for all FY26 CDMRP funding opportunities are total costs (direct plus indirect costs).

FY26 program announcements released:

The Alzheimer’s Research Program (AZRP) released program announcements for the following funding opportunities:

Transforming Care Award
Transforming Diagnosis Award
Transforming Research Award

To view the AZRP funding opportunity announcements and submit a pre-application, visit https://ebrap.org/eBRAP/public/ProgramFY.htm?programFYId=719106

The Amyotrophic Lateral Sclerosis Research Program (ALSRP) released program announcements for the following funding opportunities:

Therapeutic Idea Award
Therapeutic Development Award
Clinical Outcomes and Biomarkers Award
Pilot Clinical Trial Award

To view the ALSRP funding opportunity announcements and submit a pre-application, visit https://ebrap.org/eBRAP/public/ProgramFY.htm?programFYId=707101

The Arthritis Research Program (ATRP) released program announcements for the following funding opportunities:

(New for FY26) Translational Research Award
Clinical Research Award

To view the ATRP funding opportunity announcements and submit a pre-application, visit https://ebrap.org/eBRAP/public/ProgramFY.htm?programFYId=719108

The Breast Cancer Research Program (BCRP) released program announcements for the following funding opportunities:

Breakthrough Award- Funding Levels 1 and 2
Breakthrough Award- Funding Level 3
Breakthrough Award Funding Level 4
Clinical Research Extension Award
Era of Hope Scholar Award
Transformative Breast Cancer Consortium Award
Transformative Breast Cancer Consortium Development Award

To view the BCRP funding opportunity announcements and submit a pre-application, visit https://ebrap.org/eBRAP/public/ProgramFY.htm?programFYId=705101

The Ovarian Cancer Research Program (OCRP) released program announcements for the following funding opportunities:

Clinical Trial Award
Investigator-Initiated Research Award
Ovarian Cancer Academy – Early-Career Investigator Award
Ovarian Cancer Clinical Trial Academy – Early Career Investigator Award
Pilot Award

To view the OCRP funding opportunity announcements and submit a pre-application, visit https://ebrap.org/eBRAP/public/ProgramFY.htm?programFYId=711101

The Pancreatic Cancer Research Program (PCARP) released program announcements for the following funding opportunities:

Focused Pilot Award
Idea Development Award
Translational Research Partnership Award

To view the PCARP funding opportunity announcements and submit a pre-application, visit https://ebrap.org/eBRAP/public/ProgramFY.htm?programFYId=707102

The Spinal Cord Injury Research Program (SCIRP) released program announcements for the following funding opportunities:

Investigator-Initiated Research Award
Translational Research Award
Clinical Translation Research Award
Clinical Trial Award

To view the SCIRP funding opportunity announcements and submit a pre-application, visit https://ebrap.org/eBRAP/public/ProgramFY.htm?programFYId=719104.

Fiscal Year 2026 (FY26) pre-announcement(s) for Department of War (DOW) programs managed by the Congressionally Directed Medical Research Programs (CDMRP).

Pending approval in accordance with Executive Order 14332: “Improving Oversight of Federal Grantmaking”, the Defense Health Agency Contracting Activity will post official FY 2026 CDMRP Notices of Funding Opportunities, including submission due dates, in Grants.gov. Applicants should plan for condensed timelines for submission of both pre- and full applications. Applicants are encouraged to consult the anticipated funding opportunities (https://cdmrp.health.mil/pubs/press/press) and archived funding opportunities (https://cdmrp.health.mil/funding/archive/archive).

FY26 Pre-announcement(s) released:

The Neurofibromatosis Research Program (NFRP) released a pre-announcement for the following funding opportunities:

Exploration Hypothesis Development Award
Investigator-Initiated Research Award

Qualified Collaborator Option.
NF Open Science Initiative Option

Neurofibromatosis Research Academy – Leadership Award
Neurofibromatosis Research Academy – Scholar Award
Synergistic Idea Award

To view the NFRP pre-announcement visit https://cdmrp.health.mil/pubs/press/2026/nfrppreann

The Prostate Cancer Research Program (PCRP) released a pre-announcement for the following funding opportunities:

Data Science Award
Idea Development Award

New Investigator Option.
Established Investigator Option

Early Investigator Research Award
Physician Research Award

To view the PCRP pre-announcement visit https://cdmrp.health.mil/pubs/press/2026/pcrppreann

Fiscal Year 2026 (FY26) pre-announcement(s) for Department of War (DOW) programs managed by the Congressionally Directed Medical Research Programs (CDMRP).

FY26 Pre-announcement(s) released:

The Rare Cancers Research Program (RCRP) released a pre-announcement for the following funding opportunities:

Concept Award
Idea Development Award
Resource and Community Development Award

To view the RCRP pre-announcement visit https://cdmrp.health.mil/pubs/press/2026/rcrppreann

The Kidney Cancer Research Program (KCRP) released a pre-announcement for the following funding opportunities:

Concept Award
Idea Development Award (IDA)

o IDA with Partnering Principal Investigator Option

Academy of Kidney Cancer Investigators -Early Career Scholar Award

To view the KCRP pre-announcement visit https://cdmrp.health.mil/pubs/press/2026/kcrppreann

BrightFocus Foundation

American Heart Association

Institutional Award for Undergraduate Student Training

Proposal deadline: Wednesday, September 9, 2026
This award is made to qualified institutions that can offer a meaningful research experience that supports the AHA mission that encourages undergraduate college students from all disciplines to consider research careers.

AHA Institutional Research Enhancement Award (AIREA)

Proposal deadline: Thursday, September 10, 2026
Stimulates research at educational institutions that provide baccalaureate or advanced degrees related to scientific research training. Eligible institutions may not have been major recipients of NIH support. Awards provide funding for small-scale research projects related to cardiovascular diseases and brain health, enhancing the research environment at eligible institutions, and exposing students to research opportunities.

AHA Predoctoral Fellowship

Proposal deadline: Tuesday, August 4, 2026
Enhances the training of promising students in pre-doctoral or clinical health professional degree training programs and who intend careers as scientists, physician-scientists or other clinician-scientists, or related careers aimed at improving global health and wellbeing.

Within this award, additional collaboration money has been designated through the AHA/CHF Congenital Heart Defect Research Awards, Autism Speaks, the Barth Syndrome Foundation, the California Walnut Commission, and the Foundation for Sarcoidosis Research.

AHA Postdoctoral Fellowship

Proposal deadline: Wednesday, August 5, 2026
Enhances the training of postdoctoral applicants who are not yet independent. The applicant must be embedded in an appropriate investigative group with the mentorship, support, and relevant scientific guidance of a research mentor.

Within this award, additional collaboration money has been designated through AHA/CHF Congenital Heart Defect Research Awards, the AHA/VIVA Physician Research Award, Autism Speaks, the Barth Syndrome Foundation, the California Walnut Commission, and the Foundation for Sarcoidosis Research.

Weekly Research Updates & Guidance